Literature DB >> 2699312

Allergen immunotherapy in allergic respiratory disease in childhood.

L Kumar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2699312     DOI: 10.1007/BF02722417

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  8 in total

Review 1.  Current status of allergen immunotherapy. Shortened version of a World Health Organisation/International Union of Immunological Societies Working Group Report.

Authors: 
Journal:  Lancet       Date:  1989-02-04       Impact factor: 79.321

2.  Generation of antigen-specific suppressor cells during allergy desensitization.

Authors:  R E Rocklin; A L Sheffer; D K Greineder; K L Melmon
Journal:  N Engl J Med       Date:  1980-05-29       Impact factor: 91.245

Review 3.  Adequate clinical trials of immunotherapy.

Authors:  K Aas
Journal:  Allergy       Date:  1982-01       Impact factor: 13.146

4.  Allergy to ragweed antigen E: effect of specific immunotherapy on the reactivity of human T lymphocytes in vitro.

Authors:  J G Gatien; E Merler; H R Colten
Journal:  Clin Immunol Immunopathol       Date:  1975-05

5.  Efficacy of immunotherapy in nasobronchial allergies in children as judged by mucosal sensitivity tests.

Authors:  L Kumar
Journal:  Indian Pediatr       Date:  1977-06       Impact factor: 1.411

Review 6.  Immunotherapy for allergic respiratory disease.

Authors:  P A Eggleston
Journal:  Pediatr Clin North Am       Date:  1988-10       Impact factor: 3.278

Review 7.  Asthma in infants and children--treatment of childhood asthma: Part II.

Authors:  G S Rachelefsky; S C Siegel
Journal:  J Allergy Clin Immunol       Date:  1985-09       Impact factor: 10.793

8.  Safety and immunogenicity of immunotherapy with polymerized tree, grass, and ragweed in patients with multiple inhalant sensitivities.

Authors:  L C Grammer; M A Shaughnessy; S M Finkle; J J Shaughnessy; R Patterson
Journal:  J Allergy Clin Immunol       Date:  1986-01       Impact factor: 10.793

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.